Big pharma loves to present itself as the driving force of medical breakthroughs – an industry tirelessly pushing the boundaries of science to deliver life-saving treatments. Yet, behind the grand narratives of “innovation”, the truth is far more calculated. Rather than committing to the expensive, high-risk process of true scientific discovery, pharmaceutical giants like Sanofi, Johnson & Johnson (J&J), Roche, Pfizer, Bristol-Myers Squibb (BMS), Merck, and AstraZeneca have refined a more strategic and profitable approach: let others take risks, then swoop in to take the rewards.

The post Reclaiming Drug Discovery: Why We Need Public Pharma appeared first on PopularResistance.Org.

This post was originally published on PopularResistance.Org.